SHARE CAPITAL (Tables)

6 Months Ended

12 Months Ended

Apr. 30, 2022

Oct. 31, 2021

Equity [Abstract]

SUMMARY OF CHANGES IN COMMON SHARE PURCHASE WARRANTS

A summary of the changes in the Company’s common share purchase warrants during the six months ended April 30, 2022 are as follows:

Expiry Date	Exercise Price ($)	Weighted Average Life (Years)		October 31, 2021		Granted		Exercised			Expired/ Cancelled			April 30, 2022
November 22, 2021	CA$0.19		–		4,160,021		–		(4,080,573	)		(79,448	)		–
January 17, 2022	CA$0.19		–		7,267,914		–		(5,959,396	)		(1,308,518	)		–
January 31, 2022	CA$0.19		–		5,382,303		–		(4,341,906	)		(1,040,397	)		–
February 21, 2022	CA$0.05		–		1,505,200		–		(200,000	)		(1,305,200	)		–
March 24, 2022	CA$0.19		–		6,341,872		–		(4,515,139	)		(1,826,733	)		–
March 27, 2022	CA$0.05		–		982,025		–		(882,025	)		(100,000	)		–
April 27, 2022	CA$0.19		–		791,395		–		(791,395	)		–			–
May 9, 2022	CA$0.05		0.02		1,813,725		–		(1,000,000	)		–			813,725
May 30, 2022	CA$0.19		0.08		5,223,420		–		(276,675	)		–			4,946,745
June 17, 2022	CA$0.19		0.13		17,703,506		–		(1,393,077	)		–			16,310,429
July 18, 2022	CA$0.30		0.22		4,350,000		–		(60,960	)		–			4,289,040
August 14, 2022	CA$0.05		0.29		200,000		–		(200,000	)		–			–
February 13, 2023	CA$0.65		0.79		3,827,601		–		–			–			3,827,601
April 22, 2024	CA$0.20		1.98		–		933,333		–			–			933,333
Subtotal					59,548,982		933,333		(23,701,146	)		(5,660,296	)		31,120,873
Weighted average exercise price					CA$0.22		CA$0.20		CA$0.18			CA$0.16			CA$0.26
November 27, 2022	US$0.75		0.58		–		1,375,499		–			–			1,375,499
June 10, 2026	US$0.13		4.12		–		3,000,000		–			–			1,500,000
June 10, 2026	US$0.19		4.12		–		3,000,000		–			–			1,500,000
Subtotal					–		7,375,499		–			–			4,375,499
Weighted average exercise price					–		US$0.27		–			–			US$0.27
Total					59,548,982		8,308,832		(23,701,146	)		(5,660,296	)		38,496,372

A summary of the changes in the Company’s common share purchase warrants during the six months ended April 30, 2021 are as follows:

Expiry Date

Exercise Price ($)

Weighted Average Life (Years)

October 31, 2020

Granted

Exercised

Expired/ Cancelled

April 30, 2021

August 31, 2021*

CA$0.21

0.34

3,643,791

–

–

–

3,643,791

November 22, 2021

CA$0.19

0.56

–

5,599,171

–

–

5,599,171

January 17, 2022

CA$0.19

0.71

–

7,337,914

–

–

7,337,914

January 31, 2022

CA$0.19

0.75

–

5,382,303

–

–

5,382,303

February 21, 2022

CA$0.05

0.81

1,505,200

–

–

–

1,505,200

March 24, 2022

CA$0.19

0.90

–

6,554,172

–

–

6,554,172

March 27, 2022

CA$0.05

0.91

1,482,025

–

–

–

1,482,025

April 27, 2022

CA$0.19

0.99

–

851,395

–

–

851,395

May 9, 2022

CA$0.05

1.02

2,368,626

–

–

–

2,368,626

August 14, 2022

CA$0.05

1.29

1,110,000

–

(400,000

)

–

710,000

Total

10,109,642

25,724,955

(400,000

)

–

35,434,597

Weighted average exercise price

CA$0.11

CA$0.19

CA$0.05

–

CA$0.17

* The Company received approval of the TSX-V on January 13, 2021 and amended the expiry date of 3,643,791 warrants, extending the expiry date from January 17, 2021 to August 31, 2021, subject to acceleration if the closing price of the Company’s shares exceeds CA$0.30 per common share for at least 10 consecutive trading days.

A summary of the changes in the Company’s common share purchase warrants during the year ended October 31, 2021 are as follows:

Expiry Date	Exercise Price (CA$)		Weighted Average Life (Years)	October 31, 2020		Granted		Exercised			Expired/ Cancelled			October 31, 2021
August 31, 2021*		0.21	–		3,643,791		-		(3,118,618	)		(525,173	)		–
November 22, 2021		0.19	0.14		–		5,599,171		(1,439,150	)		–			4,160,021
January 17, 2022		0.19	0.29		–		7,337,914		(70,000	)		–			7,267,914
January 31, 2022		0.19	0.33		–		5,382,303		–			–			5,382,303
February 21, 2022		0.05	0.39		1,505,200		–		–			–			1,505,200
March 24, 2022		0.19	0.48		–		6,554,172		(212,300	)		–			6,341,872
March 27, 2022		0.05	0.49		1,482,025		–		(500,000	)		–			982,025
April 27, 2022		0.19	0.57		–		851,395		(60,000	)		–			791,395
May 9, 2022		0.05	0.61		2,368,626		–		(554,901	)		–			1,813,725
May 30, 2022		0.19	0.66		–		5,223,420		–			–			5,223,420
June 17, 2022		0.19	0.71		–		17,853,506		(150,000	)		–			17,703,506
July 18, 2022		0.30	0.79		–		4,350,000		–			–			4,350,000
August 14, 2022		0.05	0.87		1,110,000		–		(910,000	)		–			200,000
February 13, 2023		0.65	1.37		–		3,827,601		–			–			3,827,601
Total					10,109,642		56,979,482		(7,014,969	)		(525,173	)		59,548,982
Weighted average exercise price					CA$0.11		CA$0.23		CA$0.16			CA$0.21			CA$0.22

* The Company received approval of the TSX-V on January 13, 2021 and amended the expiry date of 3,643,791 warrants, extending the expiry date from January 17, 2021 to August 31, 2021, subject to acceleration if the closing price of the Company’s shares exceeds CA$0.30 per common share for at least 10 consecutive trading days.

A summary of the changes in the Company’s common share purchase warrants during the year ended October 31, 2020 are as follows:

Expiry Date	Exercise Price (CA$)		Weighted Average Life (Years)	October 31, 2019		Granted		Exercised			Expired/ Cancelled			October 31, 2020
January 17, 2021		0.21	–		–		3,643,791		–			–			3,643,791
February 21, 2022		0.05	2.31		1,505,200		–		–			–			1,505,200
March 27, 2022		0.05	2.41		3,426,025		–		(1,944,000	)		–			1,482,025
May 9, 2022		0.05	2.52		5,088,626		–		(2,720,000	)		–			2,368,626
August 14, 2022		0.05	2.79		1,310,000		–		(200,000	)		–			1,110,000
May 7, 2020*		0.07	–		3,100,000		–		(3,000,000	)		(100,000	)		–
October 4, 2020*		0.08	–		5,016,000		–		(3,425,000	)		(1,591,000	)		–
November 30, 2020*		0.08	–		6,169,926		–		(3,091,383	)		(3,078,543	)		–
January 23, 2021*		0.08	–		6,388,435		–		(3,409,160	)		(2,979,275	)		–
March 29, 2021*		0.08	–		8,188,046		–		(4,496,710	)		(3,691,336	)		–
May 13, 2021*		0.08	–		31,404,738		–		(18,050,408	)		(13,354,330	)		–
Total					71,596,996		3,643,791		(40,336,661	)		(24,794,484	)		10,109,642
Weighted average exercise price					CA$0.07		CA$0.21		CA$0.08			CA$0.08			CA$0.11

* On December 20, 2019, the Company exercised its right to call, subject to acceleration provisions, all outstanding warrants set to expire between May 7, 2020 and May 13, 2021. The expiry was amended to January 19, 2020. This expiry date was then extended to February 19, 2020. Any unexercised warrants were voided and of no value after February 19, 2020.

SCHEDULE OF ASSUMPTIONS USED

	2022		2021
Risk free rate of interest		1.34 – 2.59%		0.20% – 1.07%
Expected life of options		5 years		2 to 5 years
Exercise price of options		CA$0.40 – CA$0.58		CA$0.13 – CA$0.70
Expected annualized volatility		134.93% – 136.08%		130.88% – 140.05%
Expected dividend rate		Nil		Nil

	2021			2020
Risk free rate of interest		0.20% – 1.07	%		0.43% – 1.51	%
Expected life of options		2 to 5 years			5 years
Exercise price of options		CA$0.13 – CA$0.70			CA$0.11 – CA$0.16
Expected annualized volatility		130.88% – 140.05	%		120.13% – 188.46	%
Expected dividend rate		Nil			Nil

SCHEDULE OF STOCK OPTIONS ACTIVITY

A summary of the changes in the Company’s stock options during the six months ended April 30, 2022 are as follows:

Expiry Date	Exercise Price (CA$)		Weighted Average Life (Years)		Outstanding as at October 31, 2021		Granted		Exercised			Expired/ Cancelled			Outstanding as at April 30, 2022			Vested as at April 30, 2022
March 27, 2022		0.05		–		1,500,000		–		(750,000	)		(750,000	)		–			–
December 30, 2022		0.13		0.67		6,000,000		–		–			(150,000	)		5,850,000			5,850,000
August 12, 2023		0.05		1.28		2,290,000		–		–			(750,000	)		1,540,000			1,540,000
December 3, 2023		0.05		1.59		6,450,000		–		–			(1,000,000	)		5,450,000			5,450,000
May 22, 2024		0.12		2.06		7,900,000		–		–			(850,000	)		7,050,000			7,050,000
November 3, 2024		0.15		2.52		700,000		–		–			–			700,000			700,000
November 24, 2024		0.16		2.57		320,000		–		–			(300,000	)		20,000			20,000
March 26, 2025		0.11		2.91		100,000		–		–			–			100,000			100,000
April 23, 2025		0.12		2.98		3,350,000		–		–			(250,000	)		3,100,000			3,100,000
December 30, 2025		0.13		3.67		9,500,000		–		–			–			9,500,000			9,500,000
August 30, 2026		0.70		4.34		21,700,000		–		–			(200,000	)		21,500,000			21,350,000
October 1, 2026		0.50		4.42		1,450,000		–		–			–			1,450,000			1,450,000
December 3, 2026		0.58		4.60		–		250,000		–			–			250,000			250,000
March 7, 2027		0.40		4.85		–		500,000		–			–			500,000			500,000
April 8, 2027		0.40		4.94		–		500,000		–			–			500,000			500,000
Total						61,260,000		1,250,000		(750,000	)		(4,250,000	)		57,510,000			57,360,000
Weighted average exercise price						CA$0.33		CA$0.44		CA$0.05			CA$0.11			CA$0.34			CA$0.33
Aggregate intrinsic value					$	19,994,025									$	(2,149,050	)	$	(2,102,148	)
Weighted average remaining life						3.46										3.15			3.15

 

A summary of the changes in the Company’s stock options during the six months ended April 30, 2021 are as follows:

Expiry Date	Exercise Price (CA$)		Weighted Average Life (Years)		Outstanding as at October 31, 2020		Granted		Exercised			Expired/ Cancelled			Outstanding as at April 30, 2021		Vested as at April 30, 2021
February 11, 2021		0.05		0.03		800,000		–		–			(800,000	)		–		–
August 16, 2021		0.05		0.54		600,000		–		–			–			600,000		600,000
March 27, 2022		0.05		1.15		1,750,000		–		–			–			1,750,000		1,750,000
August 26, 2022		0.13		–		500,000		–		–			(500,000	)		–		–
December 30, 2022		0.13		1.91		–		6,150,000		–			(6,150,000	)		–		–
April 19, 2023		0.05		2.21		800,000		–		–			–			800,000		800,000
August 12, 2023		0.05		2.53		3,120,000		–		(100,000	)		–			3,020,000		3,020,000
December 3, 2023		0.05		2.84		7,000,000		–		–			–			7,000,000		7,000,000
May 22, 2024		0.12		3.31		7,950,000		–		–			–			7,950,000		7,950,000
November 3, 2024		0.15		3.76		700,000		–		–			–			700,000		700,000
November 24, 2024		0.16		3.82		900,000		–		–			–			900,000		900,000
March 26, 2025		0.11		4.15		300,000		–		–			–			300,000		300,000
April 23, 2025		0.12		4.23		4,000,000		–		–			(300,000	)		3,700,000		3,700,000
December 30, 2025		0.13		4.92		–		9,500,000		–			(9,500,000	)		–		–
Total						28,420,000		15,650,000		(100,000	)		(17,250,000	)		26,720,000		26,720,000
Weighted average exercise price						CA$0.09		CA$0.13		CA$0.05			CA$0.13			CA$0.09		CA$0.09
Aggregate intrinsic value					$	801,922									$	597,721	$	597,721
Weighted average remaining life						3.18										2.78		2.78

 

A summary of the changes in the Company’s stock options during the year ended October 31, 2021 are as follows:

Expiry Date	Exercise Price (CA$)		Weighted Average Life (Years)		Outstanding as at October 31, 2020		Granted		Exercised			Expired/ Cancelled			Outstanding as at October 31, 2021		Vested as at October 31, 2021
February 11, 2021		0.05		–		800,000		–		–			(800,000	)		–		–
August 16, 2021		0.05		–		600,000		–		(600,000	)		–			–		–
March 27, 2022		0.05		0.40		1,750,000		–		(250,000	)		–			1,500,000		1,500,000
August 26, 2022		0.13		–		500,000		–		–			(500,000	)		–		–
December 30, 2022		0.13		1.16		–		6,150,000		(100,000	)		(50,000	)		6,000,000		5,837,500
April 19, 2023		0.05		–		800,000		–		–			(800,000	)		–		–
August 12, 2023		0.05		1.78		3,120,000		–		(600,000	)		(230,000	)		2,290,000		2,290,000
December 3, 2023		0.05		2.09		7,000,000		–		(550,000	)		–			6,450,000		6,450,000
May 22, 2024		0.12		2.56		7,950,000		–		–			(50,000	)		7,900,000		7,900,000
November 3, 2024		0.15		3.01		700,000		–		–			–			700,000		700,000
November 24, 2024		0.16		3.07		900,000		–		(30,000	)		(550,000	)		320,000		320,000
March 26, 2025		0.11		3.40		300,000		–		(200,000	)		–			100,000		100,000
April 23, 2025		0.12		3.48		4,000,000		–		(300,000	)		(350,000	)		3,350,000		3,350,000
December 30, 2025		0.13		4.17		–		9,500,000		–			–			9,500,000		9,500,000
August 30, 2026		0.70		4.83		–		21,700,000		–			–			21,700,000		21,400,000
October 1, 2026		0.50		4.92		–		1,450,000		–			–			1,450,000		1,450,000
Total						28,420,000		38,800,000		(2,630,000	)		(3,330,000	)		61,260,000		60,797,500
Weighted average exercise price						CA$0.09		CA$0.46		CA$0.07			CA$0.09			CA$0.33		CA$0.32
Aggregate intrinsic value															$	19,994,025	$	19,908,026
Weighted average remaining life																3.46		3.46

A summary of the changes in the Company’s stock options during the year ended October 31, 2020 are as follows:

Expiry Date	Exercise Price (CA$)		Weighted Average Life (Years)		Outstanding as at October 31, 2019		Granted		Exercised			Expired/ Cancelled			Outstanding as at October 31, 2020		Vested as at October 31, 2020
May 31, 2020		0.08		–		400,000		–		(400,000	)		–			–		–
June 3, 2020		0.05		–		550,000		–		–			(550,000	)		–		–
February 11, 2021		0.05		0.53		1,300,000		–		–			(500,000	)		800,000		800,000
August 16, 2021		0.05		1.04		1,200,000		–		–			(600,000	)		600,000		600,000
March 27, 2022		0.05		1.65		2,000,000		–		–			(250,000	)		1,750,000		1,750,000
August 26, 2022		0.13		–		–		500,000		–			–			500,000		–
April 19, 2023		0.05		2.72		800,000		–		–			–			800,000		800,000
August 12, 2023		0.05		3.03		3,780,000		–		(100,000	)		(560,000	)		3,120,000		3,120,000
December 3, 2023		0.05		3.35		9,600,000		–		–			(2,600,000	)		7,000,000		7,000,000
May 22, 2024		0.12		3.81		10,000,000		–		–			(2,050,000	)		7,950,000		7,950,000
November 3, 2024		0.15		4.27		–		700,000		–			–			700,000		700,000
November 24, 2024		0.16		4.32		–		900,000		–			–			900,000		775,000
March 26, 2025		0.11		4.66		–		300,000		–			–			300,000		300,000
April 23, 2025		0.12		4.73		–		4,200,000		–			(200,000	)		4,000,000		3,625,000
Total						29,630,000		6,600,000		(500,000	)		(7,310,000	)		28,420,000		27,420,000
Weighted average exercise price						CA$0.07		CA$0.13		CA$0.07			CA$0.07			CA$0.09		CA$0.09
Aggregate intrinsic value															$	801,922	$	866,441
Weighted average remaining life																3.18		3.18

 

SCHEDULE OF NONVESTED STOCK OPTIONS

A summary of the changes in the Company’s nonvested stock options during the six months ended April 30, 2022 are as follows:

Expiry Date	Fair Value Per Share (CA$)		Weighted Average Life (Years)		Nonvested as at October 31, 2021		Granted		Vested			Expired/ Cancelled		Nonvested as at April 30, 2022
December 30, 2022		0.07		1.16		162,500		–		(162,500	)		–		–
August 30, 2026		0.56		4.83		300,000		–		(150,000	)		–		150,000
Total						462,500		–		(312,500	)		–		150,000
Weighted average grant date fair value – per option						CA$0.39		–		CA$0.30			–		CA$0.56
Weighted average grant date fair value – total					$	144,131		–	$	74,063			–	$	65,463

A summary of the changes in the Company’s nonvested stock options during the year ended October 31, 2021 are as follows:

Expiry Date	Fair Value Per Share (CA$)		Weighted Average Life (Years)	Nonvested as at October 31, 2020		Granted		Vested		Expired/ Cancelled		Nonvested as at October 31, 2021
December 30, 2022		0.07	1.16		–		650,000		487,500		–		162,500
August 30, 2026		0.56	4.83		–		300,000		–		–		300,000
Total					–		950,000		487,500		–		462,500
Weighted average grant date fair value – per option					–		CA$0.22		CA$0.07		–		CA$0.39
Weighted average grant date fair value – total					–	$	170,781	$	26,650		–	$	144,131